Blog
Read the latest stories from the Adaptive team
Recent Posts
Jim’s Journey: The Power of Collaboration in Blood Cancer Care
October 24, 2024
Decoding Public T-cell Signatures of Disease with Tens of Thousands of T-cell Receptor Repertoires
June 7, 2024
When the Doctor Becomes the Caregiver
March 7, 2024
Clinically Actionable Insights: A Q&A with Dr. Luciano Costa on the Final Analysis of MASTER
December 1, 2023
Immune Medicine in Action: How Adaptive Immunosequencing Helped Validate a Personalized Vaccine Trial in PDAC
August 4, 2023
Hope restored: The critical role that Minimal Residual Disease can play in blood cancer patient care
March 22, 2023
Among Multiple Myeloma Patients Receiving MRD Testing, Majority Report Meaningful Benefits
February 21, 2023
A Reflection on Blood Cancer Awareness Month: Patient Spotlight
September 29, 2022
Tackling Barriers to MRD Adoption in the Community Setting
September 8, 2022While the information is considered to be true and correct at the date of publication, changes in circumstances after the time of publication may impact on the accuracy of the information. The information may change without notice and Adaptive Biotechnologies is not in any way liable for the accuracy of any information printed and stored or in any way interpreted and used by a user.